Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2020-08-10 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
独立董事关于第一届董事会第二十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the election of the second board of directors at a specific board meeting. It discusses the qualifications and nomination procedures of board candidates, confirming compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and governance matters related to director nominations and approvals. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and does not indicate it is an announcement of a report or a certification letter, so it is not RPA or RNS.
2020-08-10 Chinese
第一届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the supervisory board (监事会) of Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the resolutions passed at the 14th meeting of the first supervisory board. It details the election and nomination of new supervisory board members and the procedural compliance with company law and regulations. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings release, and no investor presentation. The document is about board/management changes specifically related to the supervisory board members. This fits the category of Board/Management Information (MANG). The document length is short and it is a direct announcement of board member changes, not a report or presentation. Therefore, the classification is MANG with high confidence.
2020-08-10 Chinese
独立董事提名人声明（裘国华）
Regulatory Filings
2020-08-10 Chinese
独立董事候选人声明（徐志翰）
Regulatory Filings
2020-08-10 Chinese
关于关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and composition of the company's board of directors. It details the nomination and qualifications of board candidates, the election process, and related governance matters. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes and appointments in the company's board, which fits the category of Board/Management Information (MANG). The document length is 3331 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG.
2020-08-10 Chinese
关于公司产品获得FDA市场准入许可的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. about their product receiving FDA market access approval. It details the product name, classification, and significance of the approval for market entry. The document is short (864 characters) and serves as a formal notification to investors and the public about this regulatory milestone. It does not contain financial data, management discussion, or detailed report content. It is not a financial report, earnings release, or management report. It is a regulatory announcement about product approval, which fits best under Regulatory Filings (RNS).
2020-08-06 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.